Press Release: First in-human implantation of an ISSYS wireless implantable hemodynamic monitor and an LVAD will be presented at the ISHLT 34th Annual Meeting in San Diego (April 11, 2014)
LIGHTNING RELEASES –Michigan, USA, April 2014: Integrated Sensing Systems, Inc. (ISSYS) announced today that the results of the first in-human implantation of an LVAD (Left Ventricle Assist Device) together with an ISSYS miniature wireless implantable hemodynamic monitor (IHM) will be presented at the International Society for Heart and Lung Transplantation Conference, ISHLT 34th Annual Meeting and Scientific Sessions on April 10-13, 2014 in San Diego, USA. The oral presentation, entitled “First Implantation in Human of a Wireless Miniaturized Intracardiac Pressure Sensor in a Patient with a HeartMate II™,” will be presented by Professor Laila Hubbert (Linkoping University, Linkoping, Sweden) on Friday, April 11, 2014 at 10:30 AM. The abstract can be found in the following web site: http://www.ishlt.org/meetings/abstracts.asp
ISSYS wireless IHM implant distinguishes itself by being able to monitor the left side of the heart. ISSYS wireless IHM is implanted in the left atrium as an adjunct device during the LVAD surgery. Being able to noninvasively monitor the left atrium on demand provides invaluable information for intelligent adjustments of LVAD settings and also allows improved chronic patient management with advanced features such as home monitoring capability and on demand wireless data capture. A custom-made internet database allows the patients to submit the home monitored cardio waveforms to a database which provides medical staff the means to read the patient’s data at will anywhere in the world. The ISSYS wireless IHM system also allows long-term monitoring (i.e., Trending) of important parameters such as Filling Pressure. Dr. Nader Najafi, ISSYS President and CEO, stated that, “the early results are very promising and may lead to the use of ISSYS IHM implants as the standard of care for LVADs. More advanced LVAD systems consisting of two ISSYS IHM implants to monitor two heart chambers have also been considered for further development.”
Company Background: ISSYS is a leader in advanced MEMS technologies for design and manufacturing of industrial, medical, microfluidic and scientific analytical sensing applications. Founded in 1995, ISSYS is one of the oldest independent MEMS companies in the US. ISSYS operates a comprehensive, state-of-the-art MEMS fabrication facility located near Ann Arbor, Michigan. ISSYS is currently certified for ISO 9001:2008, EN13980:2002 for its ATEX (intrinsically safe products), and ISO13485:2003 standard for Class III medical devices. ISSYS is a vertically integrated company dedicated to developing and manufacturing system-level products based on MEMS technology (MEMS Inside), please visit: http://www.mems-issys.com/
Source: Integrated Sensing Systems, Inc. (ISSYS)
Contact: Nader Najafi, Ph.D.
Integrated Sensing Systems Inc. (ISSYS)
391 Airport Industrial Dr., Ypsilanti, MI 48198
Tel: (734) 547-9896 Ext. 103
Fax: (734) 547-9964
Email: [email protected]
This story was originally published by American Banking News (http://www.americanbankingnews.com) and is the sole property of American Banking News. If you are reading this article on another website, that means this article was illegally copied and re-published to this website in violation of U.S. and International copyright law. You can view the original version of this story at http://www.americanbankingnews.com/2014/04/02/first-in-human-implantation-of-an-issys-wireless-implantable-hemodynamic-monitor-and-an-lvad-will-be-presented-at-the-ishlt-34th-annual-meeting-in-san-diego-april-11-2014/
Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.